Evidence map›Paper›PMID 25740106›Full record

ArticleHaematologica2015

The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features.

Marion Eveillard, Jacques Delaunay, Steven Richebourg, Laurence Lodé, Richard Garand, Soraya Wuillème, François Duhoux, Hélène Antoine-Poirel, Catherine Godon, Marie C Béné

Open access · goldAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Multifaceted Role of PRDM Proteins in Human Cancer.International journal of molecular sciences · 2020
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Marion EveillardHematology Laboratory, University Hospital, Nantes, France marion.eveillard@chu-nantes.fr.
Jacques DelaunayHematology Clinic, University Hospital, Nantes, France.
Steven RichebourgHematology Laboratory, University Hospital, Nantes, France Cytogenetics, CHU Québec Hôpital Saint Sacrement, Québec, Canada.
Laurence LodéHematology Laboratory, University Hospital, Nantes, France.
Richard GarandHematology Laboratory, University Hospital, Nantes, France.
Soraya WuillèmeHematology Laboratory, University Hospital, Nantes, France.
François DuhouxHematologic Genetics, Clinique Universitaire Saint Luc, UCL, Brussels, Belgium.
Hélène Antoine-PoirelHematologic Genetics, Clinique Universitaire Saint Luc, UCL, Brussels, Belgium.
Catherine GodonHematology Laboratory, University Hospital, Nantes, France.
Marie C BénéHematology Laboratory, University Hospital, Nantes, France.
Centre Hospitalier Universitaire de Nantes · FRCliniques Universitaires Saint-Luc · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene ExpressionGene RearrangementDNA-Binding ProteinsHumansLeukemia, Myeloid, AcuteMyeloid-Lymphoid Leukemia ProteinProto-OncogenesTranscription FactorsDNA-Binding ProteinsMyeloid-Lymphoid Leukemia ProteinTranscription Factorsacute myeloblastic leukemiaEVI1PRDM16

Identifiers

PMID25740106
PMCPMC4349292
OpenAlexW2024483006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.